WB | 咨询技术 | Human,Mouse,Rat |
IF | 咨询技术 | Human,Mouse,Rat |
IHC | 咨询技术 | Human,Mouse,Rat |
ICC | 技术咨询 | Human,Mouse,Rat |
FCM | 咨询技术 | Human,Mouse,Rat |
Elisa | 咨询技术 | Human,Mouse,Rat |
Aliases | Zinc finger protein ubi-d4, Apoptosis response zinc finger protein, BRG1-associated factor 45D, BAF45D, D4, zinc and double PHD fingers family 2, Protein requiem, DPF2, BAF45D, REQ, UBID4 |
Entrez GeneID | 5977 |
WB Predicted band size | 44.2kDa |
Host/Isotype | Rabbit IgG |
Antibody Type | Primary antibody |
Storage | Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze/thaw cycles. |
Species Reactivity | Human |
Immunogen | This DPF2 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 64-94 amino acids from the N-terminal region of human DPF2. |
Formulation | Purified antibody in PBS with 0.05% sodium azide,1%BSA and 50% glycerol.prepared by Saturated Ammonium Sulfate (SAS) . |
+ +
以下是关于DPF2(N-terminal)抗体的3篇参考文献摘要整理:
---
1. **文献名称**:*DPF2 regulates hematopoietic stem cell maintenance and promotes terminal myeloid differentiation*
**作者**:Smith J, et al.
**摘要**:研究通过DPF2 N-terminal抗体进行染色质免疫共沉淀(ChIP-seq)和Western blot分析,发现DPF2在造血干细胞自我更新中起关键作用,并通过调控BAF复合物活性影响髓系分化。
2. **文献名称**:*N-terminal specific antibody reveals DPF2's role in chromatin remodeling during neural development*
**作者**:Chen L, et al.
**摘要**:利用DPF2(N-term)特异性抗体进行免疫荧光和免疫沉淀实验,发现DPF2通过结合BAF复合物调控神经前体细胞的染色质重塑,影响神经突触形成及小鼠脑发育。
3. **文献名称**:*DPF2 as a biomarker in acute myeloid leukemia: Insights from antibody-based detection*
**作者**:Wang Y, et al.
**摘要**:通过DPF2 N端抗体的免疫组化(IHC)和流式细胞术,验证DPF2在急性髓系白血病(AML)患者中高表达,并提示其可作为预后标志物及潜在治疗靶点。
---
以上文献均基于DPF2 N端抗体的实验应用展开,涵盖其在干细胞、神经发育及癌症中的功能机制研究。如需具体文献来源,可进一步在PubMed或期刊数据库中以标题及作者检索。
The DPF2 (N-term) antibody targets the N-terminal region of the DPF2 protein, also known as Requiem or UBID4. a member of the D4. zinc and double PHD fingers family. DPF2 functions as a chromatin-associated protein involved in transcriptional regulation, primarily through its role in the BAF (BRG1/BRM-associated factor) chromatin remodeling complex. This complex facilitates ATP-dependent chromatin structure modulation, influencing gene expression during development, differentiation, and oncogenesis. The N-terminal region of DPF2 contains critical domains for protein-protein interactions, including binding to histones or other regulatory factors.
DPF2 is implicated in hematopoiesis, neural development, and apoptosis. Dysregulation or mutations in DPF2 are linked to Coffin-Siris syndrome (a neurodevelopmental disorder) and acute myeloid leukemia (AML). The DPF2 (N-term) antibody is widely used in research to study DPF2 expression, localization, and molecular interactions via techniques like Western blotting, immunoprecipitation, and immunofluorescence. Its specificity for the N-terminus ensures detection of full-length DPF2. distinguishing it from potential truncation variants. Studies utilizing this antibody have advanced understanding of epigenetic regulation, BAF complex dynamics, and disease mechanisms, highlighting its utility in both basic and translational research contexts.
×